First tuberculosis cases in Italy resistant to all tested drugs.
about
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewExtensively drug-resistant tuberculosis: epidemiology and managementTuberculosis: From an incurable scourge to a curable disease - journey over a millenniumCarbohydrate Recognition by RpfB from Mycobacterium tuberculosis Unveiled by Crystallographic and Molecular Dynamics AnalysesQuadruple burden of HIV/AIDS, tuberculosis, chronic intestinal parasitoses, and multiple micronutrient deficiency in ethiopia: a summary of available findingsMycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human NeutrophilsRapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysisFrom multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide studyA trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosisMap the gap: missing children with drug-resistant tuberculosisBibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015)Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.Drug-resistant tuberculosis: a worldwide epidemic poses a new challengeIn vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis.Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisGrowth and cell-division in extensive (XDR) and extremely drug resistant (XXDR) tuberculosis strains: transmission and atomic force observation.Global epidemiology of tuberculosis.Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis ActivityThe role of delamanid in the treatment of drug-resistant tuberculosis.Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents.Metabolic modeling predicts metabolite changes in Mycobacterium tuberculosis.Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin-antitoxin system: implications for the design of novel antimicrobial peptidesDrug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP.Challenges and controversies in defining totally drug-resistant tuberculosis.The totally drug resistant tuberculosis (TDR-TB)Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.Insect Vectors of Disease: Untapped Reservoirs for New Antimicrobials?The medical and surgical treatment of drug-resistant tuberculosis.Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology.Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.
P2860
Q26764847-F41E180E-456B-4CB6-B228-7432E1ED3979Q26830094-D285011D-B283-46C6-A7BC-A19A59681EDBQ26865560-5E411EF0-ACD9-4F80-9667-06C6B7D5ACEAQ27678529-FD88BFB4-1F40-4200-915C-C95BC57D0DEEQ28081529-C26CFA9F-75AB-40D2-BB00-F12FBFDC1E97Q28117285-A709B624-014E-4758-ADC1-0CEBCC54FFBDQ28485912-29AFA01E-04C4-4361-9425-AACDD0095212Q28487902-564D54EE-E50B-498E-9E5E-9419CFD0B6A9Q28537897-83425E6C-9D27-45C7-ADF0-B409578A2CD2Q28547002-73260604-BACD-4979-9156-7A0B3AA941E5Q28555235-D78712B9-C9A8-4A2A-AB11-D4F1F63B4FDEQ30236048-E0F321F5-C0AC-4710-ADA5-47CB75247CCFQ30573127-7367A6E4-4C4B-44CE-A2D2-A9BCD2CD2DB3Q33595284-AE8E87D0-E3DA-4587-A419-79E6B6F32EB9Q33797084-3F893C2C-C822-4234-B88E-67622B020288Q33889335-CCE979DE-99DC-4509-BE78-FBCE2F8D820DQ33926262-775F2945-1DD9-4672-AF4F-A97783136261Q34271289-8699B4A3-D54B-44B4-B114-37529B66DD9EQ35045088-F59DFCC7-69DF-4ABD-B856-669716D208A4Q35052626-D4BBB11D-CEE7-4875-8A2F-C00EB029748CQ35624245-507BE616-6E0C-4D85-880A-8190EC883D65Q35738505-3AD8A0B3-B58F-4BA1-A721-3B3E4E7650A1Q35778015-516E5287-B1E4-46A2-ACC1-D9EA3B61EDF8Q35828310-2A504415-6D94-4EA9-B4A5-2EEF32C21615Q35868609-B9B5F497-759D-49B8-94C2-6BC8F4BD0E9FQ36002459-08DAF646-9778-4520-9D2A-A67C677F8970Q36106172-60D0773E-9688-464E-975E-D1D0FD3E0C15Q36288667-64F87100-AD7F-4518-B145-F767EE076D89Q36425928-098DBBF1-0BAF-4D6D-A491-2035C82AC4CFQ36574273-1C828C84-1346-4B76-9E5D-9FBA2EC9B6ADQ36781680-28262DCB-6709-4E5F-9551-D037F4F9B30DQ36822433-BDDC23D3-757B-4A68-A497-3B56F7552A83Q36870749-D137AB02-57D1-4B9F-8F1F-BF4CC057C03DQ36911412-E5640C74-DA09-4055-976F-4737107E6F88Q37184072-C5EFF847-EC60-4DD8-86DF-21545D4A20D5Q37525505-8D4BFE50-EF78-42C9-A220-8316D0E84DD4Q37629518-9955D30E-545D-4C4B-9B99-F27A817FD4E0Q38061197-444057DE-D6B9-4B41-8E23-7134DF0B8FC0Q40080040-16C8A470-FE22-4856-B76E-1F9ADA2C9938Q42123730-53213F78-3679-4C26-A5E8-FF483A43DC8D
P2860
First tuberculosis cases in Italy resistant to all tested drugs.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
First tuberculosis cases in Italy resistant to all tested drugs.
@ast
First tuberculosis cases in Italy resistant to all tested drugs.
@en
First tuberculosis cases in Italy resistant to all tested drugs.
@nl
type
label
First tuberculosis cases in Italy resistant to all tested drugs.
@ast
First tuberculosis cases in Italy resistant to all tested drugs.
@en
First tuberculosis cases in Italy resistant to all tested drugs.
@nl
prefLabel
First tuberculosis cases in Italy resistant to all tested drugs.
@ast
First tuberculosis cases in Italy resistant to all tested drugs.
@en
First tuberculosis cases in Italy resistant to all tested drugs.
@nl
P2093
P1433
P1476
First tuberculosis cases in Italy resistant to all tested drugs
@en
P2093
D M Cirillo
G B Migliori
P304
P356
10.2807/ESW.12.20.03194-EN
P577
2007-05-17T00:00:00Z